Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1643 | Thyroid (non-cancer) | ICEECE2012

Control of 217 hypothyroid women during pregnancy

Familiar C. , Anton T. , Marco A. , Tapia M. , Villa M. , Ramos A. , Moraga I.

Introduction: The new guidelines for the management of hypothyroidism (HP) during pregnancy recommend a tighter treatment with levothyroxine (Lt4) to reach TSH values similar to those of pregnant women without thyroid dysfunction (TSH <2.5 mU/l in the 1st trimester-T- and TSH <3mu/l in the 2nd and 3rd T).Objectives: To assess the degree of control of HP in women followed during pregnancy according to the current criteria and the possible associat...

ea0041ep557 | Diabetes therapy | ECE2016

Randomized clinical trial to compare the effects of glargine multidosis versus CSII therapy on metabolic and oxidative stress parameters in people with type 1 diabetes

de Adana Navas M Soledad Ruiz , Dominguez-Lopez Marta , Rubio Eleazara , Rodriguez Natalia Colomo , Cardona Isabel , Tapia M Jose , Morillas Virgina , Gonzlez Inmaculada , Rojo Gemma

Aims: There are few data comparing oxidative stress markers in CSII versus MDI/G We compared after randomization CSII (Continuous subcutaneous insulin infusion) vs MDI/G therapy (multiple doses of insulin with glargine) in DM1 people previously optimized at MDI/G being the primary objective assessment of metabolic control and oxidative stress.Assess oxidative stress and metabolic control in patients with type 1 diabetes (T1D) after randomization in CSII ...